New hair loss treatment DA-001 enters Large-Scale human testing
NCT ID NCT06648850
First seen Jan 11, 2026 · Last updated May 01, 2026 · Updated 21 times
Summary
This study tests a treatment called DA-001 for people with hair shedding or hair loss conditions like telogen effluvium and female or male pattern baldness. About 1,120 adults will apply the treatment to their scalp to see if it reduces shedding and helps hair grow back. The study is not yet recruiting and is in Phase 2 and 3.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALE PATTERN BALDNESS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.